Dolby Laboratories (DLB) FY2018 results: revenue $1.1 billion, down 2.5% on the year
Dolby Laboratories, Inc. (DLB) reported revenue of $1.1 billion for fiscal 2018, the year ended 28 September 2018, down 2.5% on the year before. Net income was $42 million, down 79.8%, and diluted earnings per share $0.39. The figures are the company's own, from the 10-K it filed with the SEC on 15 November 2018.
Revenue
$1.1 billion
-2.5% on the year
FY2011FY2018
Operating margin
17.4%
22.9% a year earlier
FY2011FY2018
Net income
$42 million
-79.8% on the year
FY2011FY2018
Diluted EPS
$0.39
-80.5% on the year
FY2011FY2018
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Revenue
1,055
1,081
1,026
-2.5%
Cost of revenue
128
118
109
+7.8%
Gross profit
927
963
917
-3.7%
Gross margin
87.9%
89.1%
89.4%
Research and development
237
233
220
+1.5%
Operating income
184
247
232
-25.7%
Operating margin
17.4%
22.9%
22.6%
Interest expense
0.2
0.1
0.1
+55.9%
Pre-tax income
196
255
236
-23.0%
Income tax
154
48.0
49.5
+220.7%
Effective tax rate
78.5%
18.8%
21.0%
Net income
41.7
206
186
-79.8%
Net margin
4.0%
19.1%
18.1%
Diluted EPS
$0.39
$2.00
$1.81
-80.5%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Operating cash flow
352
378
360
-6.8%
Capital expenditure
72.8
99.6
101
-26.9%
Free cash flow
279
278
259
+0.4%
Free cash flow margin
26.5%
25.7%
25.3%
Cash from investing
78.1
-158
-282
Cash from financing
-134
-107
-92.0
Depreciation and amortisation
81.3
84.3
85.2
-3.6%
Share-based compensation
71.2
65.3
67.0
+9.0%
Buybacks
150
100
101
+50.5%
Dividends paid
66.2
57.1
48.4
+15.9%
Dividend per share
$0.67
$0.58
$0.50
+15.5%
Diluted shares, weighted
107m
103m
102m
+3.6%
Balance sheet
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Shareholders' equity
2,364
2,137
1,970
+10.6%
Non-controlling interest
6.6
7.1
8.5
-7.5%
Debt
0.0
0.0
0.0
Other liabilities
495
390
331
+27.0%
Total liabilities and equity
2,865
2,534
2,310
+13.1%
Fixed assets
514
485
444
+6.0%
Goodwill
328
311
310
+5.4%
Intangible assets
184
190
215
-3.0%
Investments
366
562
516
-34.9%
Cash and equivalents
918
634
520
+44.7%
Receivables
166
73.8
75.7
+125.3%
Inventory
26.2
25.1
16.4
+4.6%
Other assets
363
252
214
+43.9%
Total assets
2,865
2,534
2,310
+13.1%
10-K for the year ended 28 September 2018, filed 15 November 2018: the filing.